Conclusion: Chemotherapy - induced neutropenia occurred 57.9% in breast cancer patients treated with 4AC - 4T regimen, 15.8% after chemotherapy cycles, there were neutropenia at grades 3 and 4 in 4, 4% chemotherapy cycles; chemotherapy - induced febrile neutropenia occurred 14% in breast cancer patients, 2.2% after chemotherapy cycles.